Bioreductive metabolism of mitomycin C in EMT6 mouse mammary tumor cells: cytotoxic and non-cytotoxic pathways, leading to different types of DNA adducts. The effect of dicumarol 4 4Abbreviations: MC, mitomycin C; DIC, dicumarol; 2,7-DAM, 2,7-diaminomitosene; and XDH, xanthine dehydrogenase.

This publication has 23 references indexed in Scilit:

• Structure of Adduct X, the Last Unknown of the Six Major DNA Adducts of Mitomycin C Formed in EMT6 Mouse Mammary Tumor Cells
  Chemical Research in Toxicology, 2000
• Pharmacological determinants of the antitumour activity of mitomycin C
  Biochemical Pharmacology, 1998
• The mitomycin bioreductive antitumor agents: Cross-linking and alkylation of DNA as the molecular basis of their activity
  Pharmacology & Therapeutics, 1997
• 2,7-Diaminomitosene, a Monofunctional Mitomycin C Derivative, Alkylates DNA in the Major Groove. Structure and Base-Sequence Specificity of the DNA Adduct and Mechanism of the Alkylation
  Journal of the American Chemical Society, 1996
• Studies on the mechanism of the cytotoxic action of the mitomycin antibiotics in hypoxic and oxygenated EMT6 cells
  Advances in Enzyme Regulation, 1993
• Bioactivation of Mitomycin C by Xanthine Dehydrogenase From EMT6 Mouse Mammary Carcinoma Tumors
  JNCI Journal of the National Cancer Institute, 1992
• Isolation, Identification, and Assay of [³H]-Porfiromycin Adducts of EMT6 Mouse Mammary Tumor Cell DNA: Effects of Hypoxia and Dicumarol on Adduct Patterns
  Cancer Communications, 1991
• Porfiromycin disposition in oxygen-modulated P388 cells
  Cancer Chemotherapy and Pharmacology, 1990
• Purification of xanthine dehydrogenase from rat liver: A rapid procedure with high enzyme yields
  Archives of Biochemistry and Biophysics, 1987
• The hypoxic tumor cell: A target for selective cancer chemotherapy
  Biochemical Pharmacology, 1980